Vetoquinol has announced that Epiphen® Solution, the phenobarbital anti-epileptic treatment for dogs, is now back in stock following a manufacturing issue that has been successfully resolved.
The company says the solution now completes the Epiphen® range to offer convenient dosing for all weights of animal as part of its overall epilepsy management package.
To order, please contact your wholesaler or Vetoquinol Territory Manager.
The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals which afford the UK additional protection against rabies, ticks and tapeworms.
The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision.
The transitional arrangements allow the UK to impose stricter measures on the entry of pet animals and are designed to protect the UK from rabies, ticks and tapeworms (Echinococcus multilocularis).
The vote in the European Parliament today supports an extension of these arrangements until the end of 2011 and puts in place a system so that permanent measures can be imposed in the future for entry to specific Member States based on scientific evidence. The decision will have to be ratified by the European Agriculture Council before coming into force.
Parasitologist Maggie Fisher from ESCCAP said: "This provides the UK with invaluable time to mount a solid scientific case for retaining the requirement for tick and tapeworm treatment indefinitely."
Professor Bill Reilly, President of the BVA, said: "The BVA and BSAVA have worked closely with Defra to secure this extension to the arrangements and we will now be pushing for investment in additional scientific research that will give us a clearer picture of the threat of the parasite Echinococcus multilocularis and other exotic and emerging diseases."
Dr Richard Dixon, President of BSAVA, added: "This decision in Europe is strongly welcomed and we are pleased that veterinary associations across Europe supported our position. The next stage is to gather further evidence to ensure the UK is protected in the future.
"In the meantime, the key message for pet owners is that they must talk to their vets as early as possible to find out how to protect them from disease and parasites when travelling abroad."
Luisa (pictured left) said: “We want to further understand the research topics and questions that UK vets believe are most critical to improving veterinary care and advancing the veterinary profession.
“We are particularly interested in the topics, issues and questions that vets think scientific evidence would help when practicing veterinary medicine, whether specific to their role or the entire profession.
"It’s vitally important to highlight potential research gaps, so we can ensure clinical studies have the greatest possible impact to help improve outcomes for our patients.”
The survey will be conducted in two parts.
The first survey will close in early March, with the second survey circulated in April for three months.
The results will be published in an online, open access peer-reviewed journal.
Survey: https://bit.ly/4ko3utN
Boehringer Ingelheim Vetmedica is giving veterinary practices the chance to offer cat owners a free 3ml pack of Metacam to trial treatment in cats with chronic pain.
Boehringer says each free Metacam pack will provide up to seven days' pain relief to an average-sized arthritic cat, and that it comes in an easy-to-administer cat friendly syringe for accurate dosing. The company also points towards a study which demonstrates that Metacam is highly palatable in 95% of cats1.
To qualify for the offer, veterinary surgeons have to fill in a redemption form logging five new cases. The offer is limited to 25 free bottles per practice. Replacement stock will be sent via your usual veterinary wholesaler. In addition, all completed forms will be entered into a prize draw to win one of six copies of the textbook 'Feline Orthopedics'
According to Boehringer, it is estimated that up to 90% of older cats (over 12 years of age) have radiographic evidence of degenerative joint disease2. However, cats may be more restrained than dogs in the way they react to chronic OA pain, and subtle behaviour changes can be a sign that cats are suffering from chronic pain3.
For further information on Metacam and the 3ml trial pack offer, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
References
The Equine Veterinary Journal (EVJ) has published a free online collection of articles which explain the current understanding of equine antimicrobial resistance and how the profession can preserve the effectiveness of these essential medicines.
The new collection comprises ten clinical reports and studies and three editorials covering current trends on bacterial populations, risk factors and the appropriate use of antimicrobials in practice.
A clinical report on the changes in bacterial populations in foals with sepsis raises the question whether the emergence of resistance in horses has occurred as a result of antibiotic use in humans, with nosocomial spread from human handlers in foals. Studies on the prevalence of faecal carriage of antimicrobial resistant E. coli show their prevalence to be common in normal horses in the community in the UK, although MRSA carriage was rare. Data suggested transmission of resistant bacteria from animals receiving antibiotics may result in carriage of bacteria by in contact animals.
The need for judicious use of antimicrobials is reinforced in a study on antimicrobial-associated diarrhoea in three equine referral practices. Two papers investigate both prescribing practice in the UK and the impact of antimicrobial use on infection and pyrexia in hospitalised horses, concluding that there are opportunities for more targeted, ‘smart’, use antimicrobials in the perioperative period, rather than simply more antimicrobials.
The final study discusses a low-cost syndromic surveillance model for monitoring healthcare associated infection in clinical practice to provide a realistic benchmark against which other hospitals may compare antimicrobial study data.
Three supporting editorials complete the online collection, giving comment on the overall situation of antimicrobial resistance in the horses, including the current political situation and antimicrobials and surgical site infection.
Professor Peter Clegg, Associate Editor of the Equine Veterinary Journal said: "It remains to be determined how big a problem antimicrobial resistance will become for the equine veterinary profession, either through greater difficulties in treating horses, or through political pressure to restrict access to antimicrobials. Meanwhile the EVJ remains committed to the promotion of responsible stewardship to best preserve the efficacy of the drugs we have got for as long as we can."
Mark Bowen, President of the British Equine Veterinary Association and guest editor said: "BEVA has a long-term commitment to promoting responsible antimicrobial use throughout the profession and supporting EAAD through the PROTECT ME brand. This year we have released resources around Education, aimed at the profession through EVJ and to the horse owning public through development of material that can be provided alongside antimicrobial dispensing. The work of the equine profession in preserving the highest priority antimicrobials will ensure efficacy can be retained for as long as is possible."
The antimicrobial online collection is available free online at: http://onlinelibrary.wiley.com/journal/10.1001/(ISSN)2042-3306/homepage/antimicrobial_resistance.htm
Produced by Knowledge’s Library and Information Service, inFOCUS watches all relevant veterinary journals and provides concise summaries of the most important, interesting or practice-critical primary and secondary material.
Subscribers to inFOCUS are sent a bi-monthly email containing the summaries – including the bottom line for implementation in practice – and the option to read the original articles.
The new service aims to remove the time constraints associated with identifying the most vital research.
A Clinical Review Team, made up of experts and specialists from across the veterinary community, assesses journals to find the best items based on relevance, quality and potential impact, and then reviews and summarises the literature for each edition of inFOCUS.
RCVS President Stephen May said: "inFOCUS is a crucial and long-awaited provision available to everyone involved in veterinary care.
"By removing the barriers to accessing and reflecting upon latest research and commentary, this innovative way of bringing you must-know updates further enforces the move towards evidence-based veterinary medicine, of which RCVS Knowledge is a champion.
"Whether you’re someone who regularly checks veterinary publications or you rarely get the chance to analyse the available material, make sure inFOCUS is on your reading list."
As well as the six-times-per-year email, inFOCUS will be viewable online, where editions from previous months will be housed and individual summaries categorised by animal type. Though initially focused on small animals, literature from across the broad spectrum of veterinary practice will be highlighted.
You can subscribe here to have the latest inFOCUS updates sent directly to your inbox.
Also, if you're interested in helping to ensure that the most important research reaches the veterinary community, you can apply to join the Clinical Review Team here.
Lax-a-Past is a palatable paste that can be administered orally to kittens and cats aged over 6 months.
It can be used weekly to help stop hairballs from forming or in higher doses over a consecutive three-day period to help eliminate them.
Carol Morgan, Brand Manager from Dechra Veterinary Products (pictured right) said: “Hairballs are a well-known issue for cats. Lax-a-Past is a complementary feed that offers a simple, easy-to-administer solution to help relieve the digestion problems caused by hairballs.
“It is very easy for owners to administer as the required dosage can be squeezed out and spread on a front paw or given directly into the mouth."
Lax-a-Past is available in a 70g tube.
For more information visit www.dechra.co.uk.
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2009 until 31st March 2010 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
ISPAH says that data from the 2009 scheme showed that 69% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
Further information and the 2010 Barren EweCheck pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
MSD Animal Health has launched Expertis Udder Health, a farm management tool for veterinary surgeons to better enable them to monitor and improve udder health in dairy cattle.
Expertis was presented to vets at the International Conference on Udder Health and Communication which took place in Utrecht this week.
Expertis Udder Health consists of a software programme together with educational and communication tools to help veterinary surgeons and farmers find the causes of mastitis more easily.
The Expertis Udder Health program consists of four steps: 1. A farm intake questionnaire about setting goals puts the farmer in a central position, and allows for careful listening in order to align with his/her objectives. 2. The data is analyzed, leading to the identification of the right focus points that are needed to identify areas for improvement. 3. These focus points are presented as fact sheets, i.e. a check list of risk factors for mastitis within the focus point. 4. The information is synthesized into an automatic summary of the actual situation, the udder health objectives and an open space to fill in the tailor-made advice to the farmer for improvement of the udder health status on his farm.
Jantijn Swinkels, DVM, Global Technical Director Pharmaceuticals within the Ruminants Business Unit at Merck Animal Health said: "The structured approach offered by Expertis Udder Health takes into account that mastitis is a multifactorial disease and covers all aspects that influence udder health. To save time, the analysis ensures that the focus is on the most important issues, which can differ greatly from farm to farm. The existing services provided within this tool can be used to optimize udder health on the farm".
Rinse Jan Boersma, MSc, Global Director Dairy Cattle at Merck Animal Health added: "We have developed Expertis to support veterinarians and farmers by improving our service level as well as to contribute to good veterinary practices by implementing preventive measures and prudent use of antibiotics."
MSD says that as a consequence of the reduced milk production, discarded milk, veterinary and treatment costs and extra labor costs, mastitis is considered the most important cause of economic loss for dairy operations. Recent data from Sweden indicates an average economic loss of €278 per case of clinical mastitis and of €60 per case of sub-clinical mastitis.*
The Expertis Udder Health program is being rolled out country to country, and will be distributed to veterinary surgeons via local MSD Animal Health representatives.
Reference
* Nielsen C, Østergaard S, Emanuelson U, Andersson H, Berglund B, Strandberg. Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds. Animal 2010;4:1758-70
The authors say the research marks a significant step forward in understanding how veterinary surgeons and owners can more effectively manage and prevent outbreaks of the disease.
For the study, researchers from the RVC, the University of Cambridge, the Swedish University of Agricultural Sciences and Redwings Horse Sanctuary, analysed more than 500 S. equi samples from across the UK between 2016 and 2022.
In particular, they wanted to better understand the relative contribution of short-term (immediately post infection) versus long-term carriers (carriers that were infected months or years prior).
The samples were collected from clinical cases sent to diagnostic laboratories by veterinary surgeons seeking confirmation of infection.
Surplus samples were submitted to the Surveillance of Equine Strangles network and then cultured in the RVC’s research laboratory and their DNA extracted and sequenced to reveal each bacterium’s complete genetic code.
Adopting an approach that combined whole genome sequencing and epidemiological data, the researchers were able to trace how strains are related and have evolved.
With the use of computer programmes, they also tracked how genetically related strains spread between horses and across regions, over time.
By adopting this approach, the team was also able to pinpoint likely transmission events and chains of infection.
The main findings were:
The research highlights the need for early diagnosis, isolation and laboratory-confirmed clearance, particularly through guttural pouch testing, before assuming a horse is infection-free.
It also advocates for tighter biosecurity and movement protocols, especially when transporting horses across regions.
Dr Abigail McGlennon, former PhD student in the Department of Pathobiology and Population Sciences at the RVC, and lead author of the paper, said: “Strangles is a challenging and distressing disease for horses, owners, yards and vets, and this work has highlighted just how easily it can be spread across the UK in a short period of time.
“This study shows how important enhanced surveillance utilising epidemiological and genomic data is to investigate and understand strangles transmission across the UK.
"Our data highlights the importance of greater awareness and adoption of post-outbreak screening protocols to confirm freedom from infection, rather than owners assuming recovery based on the resolution of clinical signs.”
Alfaxan®, Vetoquinol's injectable general anaesthetic, is one year old this month. To celebrate the occasion, and the product's use by 860 UK practices in over 80,000 procedures so far, Vetoquinol is offering a free Alfaxan party bag.
The party bag includes an Alfaxan anaesthesia monitoring chart and an Alfaxan vet brochure with dosage chart and timer. In addition, everyone who claims a party bag will be entered into a lucky dip. Ten winners will be chosen at random to receive an oesophageal stethoscope kit, containing one normal stethoscope, with a removable head, and three Portex oesophageal stethoscope probes (small, medium and large) for monitoring patient’s heart and respiratory rate.
To claim your party bag, call the dedicated Alfaxan technical support line on 0800 345 7560 or email: MyAlfaxanPartyBag@vetoquinol.co.uk.
Vetoquinol also reports a very positive response to Alfaxan from the profession during its first year. Simon Boulton, one of Vetoquinol’s Veterinary Advisors, has been conducting wet labs across the country for the company. He said: "Vets have used the wet lab service to get me along to anaesthetize patients for the day using Alfaxan. I have had a great deal of positive feedback and the product is becoming more and more widely used. Extremely smooth and reliable inductions, followed by good cardiovascular and respiratory stability were the most noticeable features of Alfaxan anaesthesia, liked by both the vets anaesthetizing the patients and the nurses who monitor them."
The RCVS Council has decided that the final enrolments for the remaining RCVS Diplomas must be made by 1 November 2012.
According to the College, this is in line with the recommendation made by the Education Policy and Specialisation Committee to Council that the RCVS should speed up the process of phasing out all of the remaining RCVS Diplomas in favour of the increasingly popular European Diplomas.
There are now such small numbers of candidates sitting RCVS Diploma exams that benchmarking and determining a consistent examination standard becomes increasingly difficult, and the examination increasingly indefensible and unsustainable. For example, in each of the past three years, only two candidates have entered the Diploma in Small Animal Surgery (Orthopaedics) exam, and there was only one candidate in 2008. Similarly, it is now usual for only one or two candidates per year to sit Diploma exams in Zoo Medicine, Cattle Health and Production or Ophthalmology.
A number of RCVS Diplomas have already been phased out, and new enrolments are no longer being taken in subjects such as Small Animal Medicine, Dermatology, Anaesthesia and Diagnostic Imaging.
Examinations will continue to be held for enrolled candidates (including candidates who enrol ahead of the 1 November 2012 deadline). The last Diploma examinations held in each subject will depend upon when its final candidates complete the pre-examination requirements. For candidates enrolling this year, this means 2019 at the latest.
The phasing out of RCVS Diplomas has been an agreed strategy of Council for many years after the then Education Strategy Steering Group recommended greater convergence with European Colleges in a report to Council in 2002 entitled "A framework for veterinary education and training for 2010 and beyond".
The position of each subject has been under review by the respective subject boards at their annual board meetings for the last few years, and some have already been closed to new entrants.
Professor Mike Herrtage, Chairman of the RCVS Diplomas and Certificates Subcommittee said: "For some subjects, there had been a perception that the European route required the candidate to follow a residency in an academic institution, which could be a barrier to UK practitioners' chances of completing a Diploma.
"However, all the European Colleges allow an alternate training route for practitioners provided the programme is planned and specified at the time of enrolment and approved by the College before training starts."
In some subjects, the European Diploma syllabus may not cover exactly the same ground as the RCVS equivalent - for example, small animal surgery encompasses both soft tissue surgery as well as orthopaedics - but the trend for residency positions in both universities and specialists practices has been to take candidates through the European style programmes, which produces more surgical specialists who thereafter can major in one aspect of another.
Mike said: "Recent experience has shown that many diplomates take the European Diploma first, and this entitles them to apply to join the list of RCVS Recognised Specialists. If they then want to specialise in a narrower field they can do so, by providing supporting data and references to show that they are practising at a specialist level in the area concerned."
Veterinary surgeons will continue to have multiple routes to RCVS Recognised Specialist status - including via European Diplomas, which also offer a route for those not in a standard residency position, American Diplomas, the RCVS Fellowship, or other such high level qualifications.
Leading human and animal health organisations – the British Medical Association (BMA), British Dental Association (BDA), British Veterinary Association (BVA) and Royal Pharmaceutical Society (RPS) - have joined forces for the first time to promote a ‘One Health’ approach to ensure responsible guardianship of antibiotics and their proper public use on European Antibiotics Awareness Day tomorrow.
Antibiotics are obviously a vital medicine for both animal and human health, and modern health systems rely on the availability and effectiveness of a range of antimicrobials to treat and prevent infections. Yet inappropriate use – such as prescribing for self-limiting infections, not finishing a prescribed course of antibiotics or habitual prophylactic use in healthy animals to prevent disease - all contribute to the development of resistant bacteria in both humans and animals.
Whilst antibiotic resistance in animals does not perhaps present the greatest immediate existential threat, there is a strong argument for a united message to the public coming from doctors, dentists, chemists and veterinary surgeons.
Quite simply, some 13M households own a pet. Pretty much all of them visit a vet at some stage, and most will be a human patient at some point in their lives. So, what a veterinary surgeon says about the use of antibiotics in animals has the potential to help transform how owners think about them when they come to visit the doctor.
A survey of general practitioner doctors last year found that 90% feel pressured by patients to prescribe antibiotics and 28% have prescribed them several times a week when not sure they are medically necessary. If veterinary surgeons refuse to prescribe them for pets unless medically necessary, explaining that they are a precious resource which can no longer be wasted, it could help relieve the pressure on doctors. The same goes for the importance of compliance; if owners learn the importance of their pet taking the full course, there's a greater chance they'll understand why they need to complete their own course of treatment.
BVA President Sean Wensley said: "Antimicrobial resistance (AMR) is too important an issue for uncoordinated approaches amongst the medical professions. We need to work together to share knowledge and successful approaches, as well as taking responsibility for not just the immediate clinical situations before us, but also for our role in supporting the health and wellbeing of wider society. An effective approach to tackling AMR is about professions and patients working together for the greater good."
BMA board of science Chair Professor Sheila the Baroness Hollins said: "Doctors have expressed significant concern about the threat of a ‘post-antimicrobial age’. It is vital that we see action to improve antimicrobial prescribing across all disciplines. Only by different professionals working together to improve antimicrobial stewardship will we start to address this major public health issue."
BDA President Professor Nairn Wilson said: "All health professionals have a responsibility to draw a line under inappropriate or unnecessary use of antibiotics. One in ten prescriptions in the UK are provided by dentists, so we’re determined to do our bit. We are facing a clear and present danger to public health, and it will only be overcome if we act together."
For further information about EAAD 2015, visit www.ecdc.europa.eu/en/EAAD
To mark EAAD 2015, BVA has produced a range of new posters to promote the responsible use of antibiotics for use in veterinary practices or as a source of information for pet owners which can be found on their website www.bva.co.uk/eaad.
Dr David Reese, Director of VetCT Australia and a Diplomate in veterinary diagnostic imaging will present: "Leveraging CT to Diagnose and Manage Unusual Pets", followed by a Q&A session.
David said: “This webinar is a fantastic opportunity to share knowledge about optimising imaging for exotic animals to reach an accurate diagnosis.
"The field of exotics imaging has rapidly advanced in recent years.
"With the increasing use of CT alongside traditional radiography, we can see so much more and provide high-quality reports to our client practices that empower them to give great care.
"We’re excited to support Exotic Vet Support with this CPD programme.”
Attendees will also receive an exclusive discount for the Exotic Vet Support Asia-Pacific (EVSAP) Conference 1st-2nd March 2024 in Sydney.
A recording of the webinar will be available after the live session, and for attendees of the EVSAP Conference.
Register here: https://vetct.zoom.us/webinar/register/WN_i_8KgMbPSeGZ-i7AbxaDqw#/registration
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
The British Equine Veterinary Association's (BEVA) Equine Rescue Fund (ERF) has taken delivery of 'Howie the Rescue Horse', the UK's first lifesized model of a horse designed specially for training vets and firefighters
Howie will be used for the practical elements of the Rescue and Emergency Medicine Training for Equine Vets courses run by BEVA in partnership with Hampshire Fire and Rescue Service's animal rescue specialists. He will also be taken on the road to vet schools and be loaned to fire and rescue services wishing to train firefighters in manual emergency equine handling techniques.
Howie was designed to the animal rescue specialist's exacting specifications by Wales-based company Big Beasts, which more usually creates bespoke models, creatures, and props for the film and television industry, as well as for museums and theme parks.
Howie has been named after Genitrix' managing director, Howard Wilder after the company (which makes equine joint treatments such as irap HY-50®Vet) stepped in to cover the significant production costs of the model.
Howard said: "Horse rescue is a complex and hazardous operation, both for the animal and those trying to rescue it and treat any injuries. As a company actively involved in equine care, we felt it was important to make a significant financial contribution to the Equine Rescue Fund. It's great that Howie has safely arrived and we hope he'll prove an important asset to the ERF."
Picture shows: Howie the Rescue Horse with (left to right) Howard Wilder and Buster Brown and Jim Green, Animal Rescue Specialists, Hampshire Fire and Rescue Service
322 farmers took part in the survey, 83% of which had a flock of over 100 ewes.
Three quarters of them had experienced abortions in their ewes during both the 2018/2019 and 2019/2020 lambing seasons. Of those that experienced abortions during the 2019/2020 lambing season, a quarter reported that the problem occurred in more than 2% of their flock and 44% of them did not ask their vet to investigate.
Katherine Timms, Ceva Animal Health’s ruminant veterinary advisor said: “Farmers who decide not to investigate why their ewes are aborting may well experience an abortion storm during the following year’s lambing season as Chlamydophila abortus, the bacteria that causes EAE, has the ability to lay latent in ewes until the next pregnancy.
“This means that one infected sheep shedding at lambing has the potential to infect multiple ewes that will almost certainly abort at their next lambing. The consequences can be financially and reproductively devastating for farmers and it’s advisable that vets raise awareness of EAE testing with their clients to help prevent this from happening. Ceva’s Assure Ewe programme offers farmers subsidised farm serology testing for Chlamydia abortus. Aborted ewes can be tested for Chlamydia abortus, ideally from three weeks to three months after lambing.”
Of the 47% of farmers that are not vaccinating against EAE, 57% said they would consider it. Reasons not to vaccinate included farmers believing that they had closed flocks (59%) and EAE not having been diagnosed (57%). Only 20% decided not to vaccinate because of cost and 25% because they did not feel it was worthwhile.
Ceva is continuing its ‘For Flock’s Sake – Vaccinate!’ initiative during 2021 to help raise awareness of EAE and highlight the importance of vaccination. This year, Ceva is also highlighting the importance of testing aborted ewes through its ‘For Flock’s Sake Get Tested’ campaign which encourages the submission of samples to a diagnostic laboratory or blood sampling after lambing has finished.
For more information, visit www.enzooticabortion.co.uk, contact your Ceva Animal Health account manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
Photo: Ewe ewe looking at?
Miss Miles and her co-defendants mistakenly believed that the animals, which included a lamb, hens, piglets, goats, a calf, dogs and a pig, were in poor condition.
They went to steal the animals from their owners' property after dark, dressed in dark clothing; some in balaclavas.
Miss Miles was sentenced to a community order for a period of 18 months rehabilitation activity requirement and 100 hours unpaid work rehabilitation, to pay £250 compensation, an £85 victim surcharge, and £400 in costs.
The Committee found that the facts of the case were proved on admission by Miss Miles and on the basis that they accepted the copy of the Certificate of Conviction.
Deciding on Miss Miles’ fitness to practise, the Committee considered the evidence before it and the advice of the Legal Assessor.
It also considered the transcript of remarks of the sentencing judge, as well as the fact that the events which led to the convictions occurred while Miss Miles was a registered veterinary nurse with the RCVS.
In terms of mitigating factors, the Committee considered that there was no financial gain associated with Miss Miles’ actions.
In terms of aggravating factors, it noted the risk of injury to animals, that Miss Miles’ behaviour was pre-meditated, that individuals had been targeted in their own homes after dark, the stress and emotional harm to the owners, and that there had been repeated criminal offending.
The Committee also considered Miss Miles’ motivations in respect of animal welfare in coming to its decision.
However, it assessed the offences to be serious, taking into account their nature and circumstances.
Paul Morris, chairing the Committee and speaking on its behalf, said: “The Committee was aware that breaches of the Code do not in themselves mean that the respondent is unfit to practise by reason of the conviction.
"However, the Committee took into account the nature and circumstances of the conviction and also considered the wider public interest.
"The Committee was satisfied that the respondent’s behaviour which led to the conviction created a real risk of harm to the animals in question, as was clear from the basis upon which the respondent was sentenced.
“Further, the behaviour which led to the conviction for the repeated offences in the circumstances in question brings the veterinary nursing profession into disrepute.
"To find otherwise would undermine public confidence in the profession and fail to uphold proper standards of conduct and behaviour.
“Accordingly, the Committee found that the conviction, set out in the charge, renders the respondent unfit to practise.”
When determining an appropriate sanction, the Committee considered the same aggravating factors it had evaluated when assessing fitness to practice. However, further mitigating factors, in addition to the fact that Miss Miles had no financial gain, included:
The Committee considered the testimonials and character references which attested to Miss Miles’ exemplary practice, integrity, professionalism, compassionate approach to animals, commitment to animal welfare, work in educating others in animal welfare, and commitment to campaigning for animal welfare.
However, it was noted that Miss Miles gave the impression to the Committee that while she accepted that it was wrong to commit the criminal offences, she also believed that her intention to protect the animals’ welfare was a justification.
Speaking on the sanction, Paul Morris said: “The Committee was of the view that the conviction was particularly serious, in that it involved offences of dishonesty on a repeated basis.
"The Committee also took into account that the respondent has invoked her beliefs to undermine an aspect of the sentencing judge’s remarks and has used those beliefs to justify her actions at the time before this Committee.
“However, the risk of re-offending is low and, as already stated, the Committee accepts the respondent’s assertion that she does not intend to break the law again, and the Committee is assured in this regard by the lack of repetition in the last six years.
"There was insight shown by the respondent into the effect of her conviction on public trust and confidence in the profession.
"The Committee weighed the demands of the public interest, as well as the previously stated mitigating and aggravating factors.
"In all the circumstances of this particular case, the Committee concluded that both a reprimand and a warning as to future conduct is sufficient and proportionate to meet the need to maintain public confidence in the profession and uphold proper standards.”
The Committee went on to consider an order of suspension but decided that this would serve no useful purpose in light of the low risk of repetition of criminal offending, the nature of which was unconnected to her daily role as an RVN.
It could see no identifiable risk to animals now and in the future.
The Committee decided that to impose a suspension would be punitive and disproportionate.
The reprimand and warning sanction imposed on the respondent will remain on her RCVS record indefinitely and will be taken into consideration should there be any future misconduct.
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
A new study from the University of Surrey, published today in the journal PLOS One, has identified the specific effects of a malformation which affects affects toy breeds.
According to researchers, Chiari malformation has become prevalent as a result of selective breeding and affects many toy dog breeds which have been bred to look more doll-like, including Griffon Bruxellois, Cavalier King Charles Spaniels, Chihuahuas and their crosses.
Researchers took brain, skull and vertebrae measurements of 155 Griffon Bruxellois and compared dogs affected by the condition with normal Griffons. They discovered that Griffons with the disease had taller foreheads and that it had also caused the shape of the brain to change, with severely affected animals having their cerebellum pushed underneath the main part of the brain.
The researchers say that although it can be asymptomatic, in many dogs Chiari malformation can cause headaches, problems with walking or even paralysis.
The condition can also affect humans and the University is working with human geneticists at the University of Montreal, in the hope that better understanding of the condition will lead to improved treatment for both dogs and humans.
Lead author, Dr Clare Rusbridge from the new School of Veterinary Medicine at the University of Surrey, said: "Chiari malformation can be described as trying to fit a big foot into a small shoe. It can be very painful, causing headaches and pressure on the brain and can result in fluid filled cavities in the spinal cord. Our latest discoveries will be significant in driving this research forward and hopefully allow us to identify which genes may be associated with the condition.
"Our next steps will be to apply our technique to other breeds with Chiari malformation and investigate more sophisticated ways of screening, so that risk of disease can be detected more easily, at an earlier age and with a single MRI scan.
"We want to engage breeders and give them practical advice about the condition, but it is also important that the public recognises that breeding dogs in a certain way to influence how they look might not be in the animal's best interest. There are responsible breeders out there, who have invested in screening and who are breeding for health as well as producing attractive puppies, and it is vital that people only look to buy from them."
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo
The PDSA has announced that it is offering free workshops to help veterinary professionals deliver new welfare checks called 'PetWise MOTs'.
The PetWise MOT checks focus on the five welfare needs, and the workshops count for seven hours CPD. The charity says that while the workshops are suitable for all members of the practice team, they should be of particular interest to nursing teams and those with a keen interest in engaging clients with the needs of their pets.
The aim of the MOT Checks is to improve pet wellbeing in the UK, following reports of a reduced level of awareness amongst the public of the five welfare needs defined by the Animal Welfare Acts.
Richard Casey, PDSA Pet Wellbeing Project Manager, said: "We know there is more to a pet’s wellbeing than just providing for their basic health needs. This unique consultation structure was developed in response to falling awareness among owners of their pets’ welfare needs, with millions of pets suffering unnecessarily. The PetWise MOTs use a simple traffic light system and personalised action plans to reverse this trend by helping to inform and engage owners about what their pets need to be healthy and happy."
The consultations were first trialled on the charity’s mobile PetCheck vehicles, then expanded to PDSA’s 51 pet hospitals. According to the charity, over 100,000 PetWise MOTs and follow up checks have now been completed in the last few years, with outcomes including:
Alison Case, a Senior Vet at Bow PDSA Pet Hospital, said: "PetWise MOTs give a really practical approach to running clinics based on the pet’s welfare needs. We’ve seen a positive impact on patient care by looking at husbandry at home as well as the clinical concerns of the patient. The consultations help to strengthen the clinic-client bond through professional support and advice. We’ve had great feedback from our clients, who are now much more aware of the routine needs of their pets and often attend for further check-ups as well as regularly purchasing preventive treatments."
The workshops will focus on dogs, cats and rabbits, although the consultations are transferable to all species.
For more information or to book a place, visit www.pdsa.org.uk/petwise or email petwise@pdsa.org.uk.
Pneumonia-induced lung damage could be costing some cattle almost 74kg a year in lost lifetime growth potential with even moderate damage resulting in animals losing 39kg over an 18 month beef finishing system. These are the figures from a major collaborative study between Schering-Plough and Blade Farming, announced yesterday. They suggest that some producers may not be treating cattle pneumonia as effectively as they could. The project also highlights how better abattoir feedback can be used to improve cattle pneumonia management regimes on farm. In the study, 645 commercial beef animals from 15 units were examined at slaughter for evidence of lung damage. Data on carcase weight, age and grade were also collected to allow estimated daily live weight gains (EDLWG) to be recorded. According to project co-ordinator Paul Williams MRCVS from Schering-Plough, the research team recorded a significant level of pneumonia-induced lung damage in the slaughtered cattle. “Nearly half the cattle (48%) examined on the slaughter line had some level of lung damage. But there was also huge variation between units, with all the cattle from one particular farm having damaged lungs,” he said. The researchers also established that the extent of lung damage was strongly associated with reduced EDLWG. “The more lung lobes that are affected, the greater the potential daily liveweight gain loss and those cattle that had the most lung damage experienced a significant reduction in EDLWG of 202g per day throughout their entire lifetime. “For the animals with any degree of lung damage (310 cattle), the average reduction in weight gain over 14 months was 15kg – equivalent to a financial loss of £16.90 per animal based on a live weight price of £1.10 per kg. So the overall loss for this group of animals was potentially £5,239 – money the industry simply cannot afford to lose,” Paul Williams stressed. “In addition, those carcases with lung damage were significantly more likely to have a lower conformation grade and so receive an even lower price,” he explained. Blade Farming managing director Richard Phelps pointed out that the study had convinced him that paying closer attention to minimising pneumonia-induced lung damage could easily make some beef producers an extra £40-£50 an animal. “All the cattle we take look healthy, but I’ve been surprised at the level of undetected lung damage once the animals have been slaughtered. This lung scoring trial work in the abattoir is now helping us assess just how much lung damage diseases like pneumonia can cause. The feedback will be able to help producers reassess early stage rearing issues and be more vigilant. It’s not just grading issues that we are concerned about. Blade Farming consultant veterinary surgeon Rob Drysdale from the Westpoint Veterinary Group stressed that whilst pneumonia prevention should be the number one objective for all cattle producers, having an effective disease treatment protocol in place is increasingly vital – and particularly one that prevents permanent lung damage from occurring. He said: "Pneumonia infections can quickly damage lungs and once this happens the animal will not be able to express its full genetic potential. This means that even if the affected animal survives it is likely to have damaged lungs for the rest of its life, and this will reduce productivity and growth." T
Dechra Veterinary Products has picked up a major award at the 2011 Veterinary Marketing Awards for a calendar called 'The Horse in History'.
The calendar, designed to promote all of Dechra's equine products but particularly Equipalazone, also won the award for most innovative use of direct mail. The company's website, http://www.dechra.co.uk/, was highly commended in the New Media category.
The John O'Hara Award is made to the VMA category finalist which, in the opinion of the judges, best demonstrates a high level of innovation or adventurousness in an aspect of the advertising mix. Designed to celebrate the unique position of the horse down the ages in culture, art, science and legend, the calendar featured twelve iconic illustrations, from the white horse carved into the chalk hillside in Uffington, Oxfordshire, to Da Vinci's sculpture.
It also included an embedded competition giving practices the opportunity to win practical aids, including wind up torches and water bottles, with the major prize being a trip to Vienna to see the Lipizzaner Stallions at the Spanish Riding School.
Larry King, Senior Brand Manager at Dechra, said: "Horses have had a unique relationship with man for thousands of years and this is what we wanted to celebrate with our calendar. The monthly competition with 100 prizes on offer and the special prize draw at the end of the year gave it a real point of difference and it proved very popular with our customers. It was the first time we'd run such a campaign over twelve months and we believe it to be unique in the animal health sector.
"We were delighted and honoured to win both the award for best use of direct mail and the John O'Hara award for The Horse in History. It will inspire us on our quest to continually set new standards in the way we communicate with our customers."
The Norman Cavalry
Galloping Horse
The Uffington White Horse
The Anatomy of The Horse
Incitatus
Bucephalus
Altamira Cave Painting
Gran Cavallo
Rocinante
American Carousel Horse
Aethenoth